ATE459886T1 - Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom - Google Patents

Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom

Info

Publication number
ATE459886T1
ATE459886T1 AT04740845T AT04740845T ATE459886T1 AT E459886 T1 ATE459886 T1 AT E459886T1 AT 04740845 T AT04740845 T AT 04740845T AT 04740845 T AT04740845 T AT 04740845T AT E459886 T1 ATE459886 T1 AT E459886T1
Authority
AT
Austria
Prior art keywords
metastasic
predicting
ability
mammary carcinoma
sample
Prior art date
Application number
AT04740845T
Other languages
English (en)
Inventor
Vesna Evtimova
Ulrich Weidle
Robert Zeillinger
Original Assignee
Robert Zeillinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Zeillinger filed Critical Robert Zeillinger
Application granted granted Critical
Publication of ATE459886T1 publication Critical patent/ATE459886T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04740845T 2003-07-11 2004-07-09 Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom ATE459886T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03015584 2003-07-11
PCT/EP2004/007561 WO2005005989A1 (en) 2003-07-11 2004-07-09 A method for predicting the metastatic potential of breast cancer

Publications (1)

Publication Number Publication Date
ATE459886T1 true ATE459886T1 (de) 2010-03-15

Family

ID=34042827

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04740845T ATE459886T1 (de) 2003-07-11 2004-07-09 Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom

Country Status (4)

Country Link
EP (1) EP1646874B1 (de)
AT (1) ATE459886T1 (de)
DE (1) DE602004025812D1 (de)
WO (1) WO2005005989A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100068207A1 (en) * 2005-04-07 2010-03-18 Abdallah Fanidi DDR2 in Cancer Diagnosis, Detection and Treatment
WO2008070090A2 (en) 2006-12-05 2008-06-12 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
WO2008086799A1 (en) * 2007-01-15 2008-07-24 Aarhus Universitet Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 1 (presence)
WO2008086800A2 (en) * 2007-01-15 2008-07-24 Aarhus Universitet Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 16
WO2008132752A2 (en) * 2007-05-01 2008-11-06 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for predicting cancer metastasis
EP3364190A1 (de) * 2017-02-20 2018-08-22 Panka Cancer Research AG Verfahren zum nachweis von krebs oder krebszellen
EP3897837A4 (de) * 2018-12-21 2023-08-16 Ionis Pharmaceuticals, Inc. Verbindungen und verfahren zur verringerung der pmp22-expression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680175B2 (en) * 1998-05-05 2004-01-20 Adherex Technologies, Inc. Methods for diagnosing and evaluating cancer

Also Published As

Publication number Publication date
EP1646874A1 (de) 2006-04-19
WO2005005989A1 (en) 2005-01-20
DE602004025812D1 (de) 2010-04-15
EP1646874B1 (de) 2010-03-03

Similar Documents

Publication Publication Date Title
Lim et al. Liquid biomarkers in melanoma: detection and discovery
Stopfer et al. High-density, targeted monitoring of tyrosine phosphorylation reveals activated signaling networks in human tumors
DE60043896D1 (de) Verfahren zum nachweis von lungenneoplasmen in fäkalen proben
TW200626899A (en) Frizzled proteins and detection and treatment of cancer
DE60226271D1 (de) Verfahren zum nachweis von prostatakrebs
JP2015537210A (ja) 循環腫瘍細胞のインビトロでの捕捉および解析
DE60041839D1 (de) Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs
Chen et al. Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics
NO20074389L (no) Bestemmelse av respondere til kjemoterapi
ATE508753T1 (de) Assays und verfahren unter verwendung von biomarkern
UA95087C2 (en) Methods for pores using
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE508205T1 (de) Tests und verfahren unter verwendung von biomarkern
HK1118337A1 (en) Methods for altering one or more parameters of a measurement system
ATE459886T1 (de) Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom
ATE426043T1 (de) Verfahren zur identifizierung des brustkrebsrisikos
ATE397098T1 (de) Verfahren zur diagnostik von eierstock endometriose
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
ATE479778T1 (de) Verfahren zur diagnose nicht-kleinzelliger lungenkarzinome über die trna-dihydrouridin- synthaseaktivität von urlc8
ATE394417T1 (de) Sonde zum nachweis von nukleinsäuren
Chen et al. High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1646874

Country of ref document: EP